Creo Medical Group PLC (AIM:CREO), a world leader in minimally invasive surgical endoscopy, has been honoured with a King's Award for Enterprise in Innovation, which will be formally presented at a ceremony at Windsor Castle on July 9.
Established by Royal Warrant in 1965, the King's Awards honours and celebrates achievements in innovation, international trade, sustainable development, and social mobility.
The award highlights Creo's significant contributions to the medical device industry, particularly in the development of technologies that enable less invasive surgical procedures.
During the event, His Majesty, King Charles, will meet with Creo's CEO, Craig Gulliford, alongside other recipients from across the UK.
"We are delighted to receive this award from His Majesty The King at a Royal reception in recognition of our team's outstanding work, dedication and achievements towards innovation in healthcare," said Gulliford.
"I would like to put on record my thanks to the whole team in their daily commitment to improving patient outcomes, cutting waiting times and saving the NHS money.
"Innovation has always been at the heart of Creo, and the increasing adoption of our pioneering technology by clinicians around the world reflects the significant benefits that innovation can bring to both patients and healthcare systems."
Winners of the King's Awards can use the King’s Awards emblem for five years.